You have access
The PARP Inhibitor, ABT-888 Potentiates Temozolomide: Correlation with Drug Levels and Reduction in PARP Activity In Vivo
JOANN P. PALMA, LUIS E. RODRIGUEZ, VELITCHKA D. BONTCHEVA-DIAZ, JENNIFER J. BOUSKA, GAIL BUKOFZER, MILAGROS COLON-LOPEZ, RAN GUAN, KENNETH JARVIS, ERIC F. JOHNSON, VERED KLINGHOFER, XUESONG LIU, AMANDA OLSON, MARY J. SALTARELLI, YAN SHI, JASON A. STAVROPOULOS, GUI-DONG ZHU, THOMAS D. PENNING, YAN LUO, VINCENT L. GIRANDA, SAUL H. ROSENBERG, DAVID J. FROST and CHERRIE K. DONAWHO
Anticancer Research September 2008, 28 (5A) 2625-2635;